Detection of ErbB2 oversignalling in a majority of breast cancers with phosphorylation-state-specific antibodies

Lancet. 1999 May 8;353(9164):1591-2. doi: 10.1016/S0140-6736(99)01095-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Neoplasm*
  • Antibody Specificity*
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / immunology
  • Breast Neoplasms / metabolism*
  • Humans
  • Phosphorylation
  • Prognosis
  • Receptor, ErbB-2 / immunology
  • Receptor, ErbB-2 / physiology*
  • Signal Transduction*

Substances

  • Antibodies, Neoplasm
  • Receptor, ErbB-2